JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 125 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $32,864,000 | – | 3,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 9,200,349 | $64,402,000 | 44.86% |
TRV GP III, LLC | 3,048,780 | $21,342,000 | 1.83% |
SILVERARC CAPITAL MANAGEMENT, LLC | 406,665 | $2,847,000 | 1.65% |
Sofinnova Investments, Inc. | 925,280 | $6,477,000 | 0.39% |
Omega Fund Management, LLC | 334,965 | $2,345,000 | 0.35% |
Yorktown Management & Research Co Inc | 49,200 | $344,000 | 0.31% |
Woodline Partners LP | 940,902 | $6,586,000 | 0.18% |
HUSSMAN STRATEGIC ADVISORS, INC. | 51,000 | $357,000 | 0.09% |
HORIZON FINANCIAL SERVICES, LLC | 12,005 | $84,000 | 0.08% |
Gyon Technologies Capital Management, LP | 26,893 | $188,000 | 0.06% |